These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3477812)
1. Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. Bernards R; Destree A; McKenzie S; Gordon E; Weinberg RA; Panicali D Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6854-8. PubMed ID: 3477812 [TBL] [Abstract][Full Text] [Related]
2. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus. Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Hsieh CJ; Kim TW; Hung CF; Juang J; Moniz M; Boyd DA; He L; Chen PJ; Chen CH; Wu TC Vaccine; 2004 Sep; 22(29-30):3993-4001. PubMed ID: 15364449 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo. Drebin JA; Link VC; Greene MI Oncogene; 1988 Apr; 2(4):387-94. PubMed ID: 2896329 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice. Zaloudik J; Li W; Jacob L; Kieny MP; Somasundaram R; Acres B; Song H; Zhang T; Li J; Herlyn D Cancer Gene Ther; 2002 Apr; 9(4):382-9. PubMed ID: 11960289 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Drebin JA; Link VC; Weinberg RA; Greene MI Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9129-33. PubMed ID: 3466178 [TBL] [Abstract][Full Text] [Related]
7. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Drebin JA; Link VC; Stern DF; Weinberg RA; Greene MI Cell; 1985 Jul; 41(3):697-706. PubMed ID: 2860972 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo. Drebin JA; Link VC; Greene MI Oncogene; 1988 Mar; 2(3):273-7. PubMed ID: 2451200 [TBL] [Abstract][Full Text] [Related]
9. [Non-replicating recombinant vaccinia virus expressing HPV16 E6 and E7 proteins elicits anti-tumor immunity in mice]. Luo WF; Han LQ; Ren J; Tian HW; Lu ZH; Zhao L; Gu SY; Ruan L Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):335-9. PubMed ID: 12921560 [TBL] [Abstract][Full Text] [Related]
10. Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor. Talarico D; Ittmann M; Balsari A; Delli-Bovi P; Basch RS; Basilico C Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4222-5. PubMed ID: 2190216 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12. Mackova J; Kutinova L; Hainz P; Krystofova J; Sroller V; Otahal P; Gabriel P; Nemeckova S Int J Oncol; 2004 Jun; 24(6):1581-8. PubMed ID: 15138603 [TBL] [Abstract][Full Text] [Related]
12. Manipulation of the immune response of mice against neu/HER2-expressing tumours. Taylor P; Quinones D; Gerder M; Moros Z Oncol Rep; 1998; 5(6):1535-9. PubMed ID: 9769401 [TBL] [Abstract][Full Text] [Related]
13. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line. Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394 [TBL] [Abstract][Full Text] [Related]
14. Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. Hareuveni M; Gautier C; Kieny MP; Wreschner D; Chambon P; Lathe R Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9498-502. PubMed ID: 2251291 [TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen. Acres RB; Hareuveni M; Balloul JM; Kieny MP J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):136-43. PubMed ID: 8280702 [TBL] [Abstract][Full Text] [Related]
17. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Bargmann CI; Hung MC; Weinberg RA Cell; 1986 Jun; 45(5):649-57. PubMed ID: 2871941 [TBL] [Abstract][Full Text] [Related]
18. Experimental therapy of HPV16 induced tumors with IL12 expressed by recombinant vaccinia virus in mice. Nemeckova S; Sroller V; Hainz P; Krystofova J; Smahel M; Kutinova L Int J Mol Med; 2003 Nov; 12(5):789-96. PubMed ID: 14533011 [TBL] [Abstract][Full Text] [Related]
19. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant. Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358 [TBL] [Abstract][Full Text] [Related]
20. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9. Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]